G1 Therapeutics, Inc. (GTHX)
Sep 18, 2024 - GTHX was delisted (acquired by Pharmacosmos)
7.15
0.00 (0.00%)
Inactive · Last trade price
on Sep 17, 2024
G1 Therapeutics Employees
G1 Therapeutics had 100 employees as of December 31, 2023. The number of employees decreased by 70 or -41.18% compared to the previous year.
Employees
100
Change (1Y)
-70
Growth (1Y)
-41.18%
Revenue / Employee
$581,950
Profits / Employee
-$447,700
Market Cap
378.17M
Employees Chart
GTHX News
- 2 months ago - Pharmacosmos Group and G1 Therapeutics Announce Successful Closing of Tender Offer - GlobeNewsWire
- 2 months ago - Pharmacosmos Group and G1 Therapeutics Announce Expiration of Hart-Scott-Rodino Waiting Period - GlobeNewsWire
- 3 months ago - G1 THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of G1 Therapeutics, Inc. - GTHX - Business Wire
- 3 months ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates GTHX, PETQ on Behalf of Shareholders - GlobeNewsWire
- 3 months ago - G1 Therapeutics Provides Second Quarter 2024 Financial Results and Operational Highlights - GlobeNewsWire
- 3 months ago - Pharmacosmos Group to Acquire G1 Therapeutics - GlobeNewsWire
- 4 months ago - G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024 - GlobeNewsWire